InSteps Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $527K

  • Investors
  • 3

InSteps General Information

Description

Developer of an in-silico computational platform intended to simulate and optimize endovascular thrombectomy devices for acute ischemic stroke treatment. The company's platform integrates AI-generated synthetic vessel and thrombus anatomies, finite element modeling, generative AI-based emulation of device-tissue interactions, and virtual clinical trial simulation, enabling medical device manufacturers to accelerate preclinical-to-clinical translation, reduce reliance on physical trials, and streamline regulatory approval of neuro-thrombectomy devices.

Contact Information

Website
www.insteps.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Meibergdreef 5
  • Building Entrance Panama AUMC Location AMC APC
  • 1105 AZ Amsterdam
  • Netherlands
+31 06
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Corporate Office
  • Meibergdreef 5
  • Building Entrance Panama AUMC Location AMC APC
  • 1105 AZ Amsterdam
  • Netherlands
+31 06

InSteps Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InSteps Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Jan-2026 $527K Completed Generating Revenue
2. Seed Round 04-Sep-2023 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view InSteps’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InSteps Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InSteps Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovatiefonds Noord-Holland Venture Capital Minority
Amsterdam UMC Ventures Holding Venture Capital Minority
LifeSciences@Work Accelerator/Incubator
To view InSteps’s complete investors history, request access »

InSteps FAQs

  • When was InSteps founded?

    InSteps was founded in 2023.

  • Where is InSteps headquartered?

    InSteps is headquartered in Amsterdam, Netherlands.

  • What is the size of InSteps?

    InSteps has 6 total employees.

  • What industry is InSteps in?

    InSteps’s primary industry is Other Healthcare Technology Systems.

  • Is InSteps a private or public company?

    InSteps is a Private company.

  • What is InSteps’s current revenue?

    The current revenue for InSteps is .

  • How much funding has InSteps raised over time?

    InSteps has raised $527K.

  • Who are InSteps’s investors?

    Innovatiefonds Noord-Holland, Amsterdam UMC Ventures Holding, and LifeSciences@Work have invested in InSteps.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process